BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25031013)

  • 1. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
    Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
    Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation NKX2.2 IHC and
    Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
    Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
    McCuiston A; Bishop JA
    Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
    Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
    Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
    Russell-Goldman E; Hornick JL; Qian X; Jo VY
    Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
    Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
    Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma.
    Yamamoto Y; Yamazaki K; Ishida Y
    J Cytol; 2015; 32(1):30-2. PubMed ID: 25948942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
    Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
    Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.
    Llombart-Bosch A; Machado I; Navarro S; Bertoni F; Bacchini P; Alberghini M; Karzeladze A; Savelov N; Petrov S; Alvarado-Cabrero I; Mihaila D; Terrier P; Lopez-Guerrero JA; Picci P
    Virchows Arch; 2009 Nov; 455(5):397-411. PubMed ID: 19841938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of CD99 immunoreactivity and EWS/FLI1 translocation by fluorescence in situ hybridization in central PNETs and Ewing's sarcoma family of tumors.
    Vural C; Uluoğlu O; Akyürek N; Oğuz A; Karadeniz C
    Pathol Oncol Res; 2011 Sep; 17(3):619-25. PubMed ID: 21267687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
    Zota V; Siegal GP; Kelly D; Bridge JA; Berglund A; Bui K; Khalil F; R Reed D; Altiok S; Magliocco A; Bui MM
    Fetal Pediatr Pathol; 2023 Apr; 42(2):241-252. PubMed ID: 36062956
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
    Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
    Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of a monoclonal ERG/FLI1 antibody for immunohistochemical discrimination of Ewing family tumors.
    Tomlins SA; Palanisamy N; Brenner JC; Stall JN; Siddiqui J; Thomas DG; Lucas DR; Chinnaiyan AM; Kunju LP
    Am J Clin Pathol; 2013 Jun; 139(6):771-9. PubMed ID: 23690120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
    Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of EWS and FLI-1 proteinss in Ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression.
    Llombart-Bosch A; Navarro S
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):255-60. PubMed ID: 11556754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.